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Background: Genome-wide expression profiling using microarrays or sequence-based technologies allows us to
identify genes and genetic pathways whose expression patterns influence complex traits. Different methods to
prioritize gene sets, such as the genes in a given molecular pathway, have been described. In many cases, these
methods test one gene set at a time, and therefore do not consider overlaps among the pathways. Here, we
present a Bayesian variable selection method to prioritize gene sets that overcomes this limitation by considering all
gene sets simultaneously. We applied Bayesian variable selection to differential expression to prioritize the molecular
and genetic pathways involved in the responses to Escherichia coli infection in Danish Holstein cows.
Results: We used a Bayesian variable selection method to prioritize Kyoto Encyclopedia of Genes and Genomes
pathways. We used our data to study how the variable selection method was affected by overlaps among the
pathways. In addition, we compared our approach to another that ignores the overlaps, and studied the differences
in the prioritization. The variable selection method was robust to a change in prior probability and stable given a
limited number of observations.
Conclusions: Bayesian variable selection is a useful way to prioritize gene sets while considering their overlaps.
Ignoring the overlaps gives different and possibly misleading results. Additional procedures may be needed in cases
of highly overlapping pathways that are hard to prioritize.
Keywords: Bayesian variable selection, Gene set, OverlapBackground
Genome-wide expression profiling using microarrays or
sequence-based technologies allows us to identify genes
and genetic pathways whose expression patterns influ-
ence complex traits. It is likely that many phenotypic dif-
ferences are manifested by small but consistent
expression changes in a set of genes (e.g. biological path-
ways, complexes or modules). Therefore statistical meth-
ods have been developed to capture changes in the
expression of pre-defined sets of genes. These gene set
approaches are complementary to analyses at the single-
gene level and represent powerful tools to dissect the
complex changes in gene expression that underlie
phenotypic traits [1].
Gene set approaches are based on sets of genes typic-
ally defined based on prior biological knowledge, such as* Correspondence: peter.sorensen2@agrsci.dk
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reproduction in any medium, provided the origgenes belonging to the same molecular pathway (Kyoto
Encyclopedia of Genes and Genomes (KEGG)) [2] or
genes encoding proteins with similar functions (e.g.,
Gene Ontology (GO)) [3]. One potential problem is that
genes can exist in many gene sets and the level of over-
lap can be substantial. This is ignored in statistical ana-
lyses where the gene sets are analyzed individually,
which can cause difficulty in interpreting the results, be-
cause one cannot determine from the available data
which one of the gene sets is more responsible for the ef-
fect. In the most extreme case, there could be one or
more that are identical. In these cases it is impossible to
determine which is responsible for the effect [4].
One powerful gene set approach is Gene Set Enrich-
ment Analysis (GSEA) [1,5]. GSEA aggregates the per-
gene statistics within a gene set, thus making it possible
to detect situations where all the genes in a predefined
set change in a small but coordinated way. GSEA can be
implemented in a manner similar to a linear regression
modeling approach that consists of three components:l Ltd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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per-gene statistic vector, e.g., the t-statistic, and a per-set
summing function. In this way, a large number of gene
sets and overlapping gene sets can be viewed as a linear
regression with a large number of highly collinear regres-
sion variables. This is a typical combinatorial and model
selection problem. One way of handling this problem
has been to use linear modeling to select a model [4].
This could, for example, be achieved using Akaike’s In-
formation Criterion (AIC) [6]. However, the optimiza-
tions according to this criterion should in principle
compare all 2p possible models (where P is the number
of gene sets). This becomes computationally demanding
as the number of gene sets increases.
Another way to consider the overlaps is the TopGO
approach [7]. This takes into account the hierarchical
structure of the gene sets among GO terms. However,
this method is limited to overlaps that appear because of
this hierarchical structure. The DAVID gene classifica-
tion tool is another method that takes account of over-
laps [8,9]. In this tool, the more highly overlapping gene
sets are organized as groups [10]. This method analyzes
these groups of gene sets instead of the individual gene
sets, and makes it possible to score the groups according
to the scores of the member gene sets.
In this study we present a gene set approach based on
the Bayesian variable selection method, known as Sto-
chastic Search Variable Selection (SSVS) [11]. The Mar-
kov chains underlying such Bayesian methods are
efficient at handling combinatorial problems such as
model selection. This approach can deal with a large
number of gene sets and considers the overlaps among
the gene sets. Instead of first finding the gene sets with
significant effects and thereafter assessing their overlaps
and correcting for the correlations among them, this ap-
proach should accomplish this process in just one step.
The focus now is to investigate how the variable selec-
tion procedure analyzes the overlaps among gene sets
and how this affects the prioritization of gene sets. Here,
we demonstrate the use of this novel gene set approach
in a genome-wide expression study of Escherichia coli-
induced mastitis (udder infection) in dairy cattle.
Methods
The gene set approach presented in this study is based on a
linear model to identify and prioritize KEGG pathways
whose expression levels are associated with bovine mastitis.
Gene sets defined by KEGG pathways
KEGG pathways were used as gene sets. These pathways
are a collection of high-quality molecular interaction and
reaction networks representing the current knowledge of
many important biological processes. The use of KEGG
pathways as gene sets illustrates situations where thenumber of gene sets is relatively large and where the
level of overlap among the gene sets is substantial. We
used 196 KEGG pathways and 3130 bovine Entrez gene
identifiers. Only KEGG pathways containing more than
four genes were included. The number of genes in a set
ranged from five to 793 (‘Metabolic Pathways’). The
number of occurrences of the same gene across pathways
ranged from one to 41. The KEGG pathways were taken
from the KEGG database using the genome-wide anno-
tations of bovine Entrez gene identifiers.
Scaling up the analysis to higher dimensions and to
cases with increased overlap, as when GO is used to define
gene sets, was not expected to be problematic. The current
analysis uses little memory and computing time, and both
will scale-up linearly in these Bayesian implementations.
With higher overlaps among gene sets, worse mixing for
gene effects among sets can be expected, probably requir-
ing some increase in the Markov chain Monte Carlo chain
length to obtain accurate estimates.
Linear model
The gene set approach is based on a linear model that in
matrix notation can be written as
z ¼ μþ Xβþ e;
where z is the per-gene statistic (e.g., t-statistic), which is
a measure of the association between the individual genes
and the trait phenotype; μ is the general mean; X is an in-
cidence matrix linking genes to the gene set and the per-
gene statistic z. The residuals e are assumed to be independ-
ent and identically distributed according to e ~ N (0, Iσ²).
The elements of the incidence matrix have a non-zero value
if the gene belongs to the gene set and zero otherwise. To
account for direction of the expression changes we used a
−1 for genes that are down regulated and a 1 for those that
are up regulated. Each row of the incidence matrix corre-
sponds to a gene and each column to a gene set. For this
study, the full incidence matrix had 3130 rows (correspond-
ing to the total number of genes) and 196 columns (corre-
sponding to the total number of KEGG pathways)
(Additional file 1); β is the regression coefficient that is the
summary statistic for each pathway.
ANOVA
Analysis of Variance (ANOVA) can be used to identify
gene sets that explain a larger proportion of the variance
in z, using the least squares technique. This can be
achieved by fitting one gene set at a time and ignoring
the overlap among gene sets [4]. To account for the
overlap it is necessary to fit multiple gene sets simultan-
eously. The total number of models possible to create
from this is 2p, where p is the number of gene sets. This
could become computationally challenging for model se-
lection based on comparisons of all possible models such
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one gene set at a time was used as the reference method
in comparison to the Bayesian variable selection method
described in detail below. The test was corrected for
multiple testing using the false discovery rate method of
Benjamini and Yekutieli [12].
Bayesian variable selection method
The Bayesian variable selection method was built on the
linear model described above. It considers all gene sets
simultaneously to identify the best multi-gene-set model
to explain the data. The large number of gene sets is
handled by SSVS [11]. The latent variable, γi, is used,
which can take the values one or zero to indicate
whether a gene set (KEGG pathway) contributes to dif-
ferences in the expression t-statistic. The distribution of
the regression coefficient βi is conditioned on γi by
βi γ ie 1 γ i
 
N 0; τ20






Figure 1 Dendrogram of the relative overlaps among all KEGG pathw
the smaller of the two sets. The black bars to the left show the pathways
pathways are not shown.The model uses a small prior probability for γi to be 1,
and τ20 is chosen to be a small number while τ
2
1 is condi-
tioned to be larger thanτ20 and is estimated from the data,
which has the effect that most regression coefficients β
i
are (very) small. γ
i=1 indicates that KEGG pathway i is
present in the model and γi=0 indicates that KEGG path-
way i is absent from the model. The details of the Bayesian
analysis are given in Additional file 2.
Both the dimension problem and the problem of compar-
ing all 2p models are countered by the use of Gibbs sampling
[13]. The Gibbs sampler generates sequences of Markov
chain Monte Carlo samples of the latent variables that con-
verge rapidly to the posterior distributions of the latent vari-
ables. The Gibbs sampler also generates a sequence of β
values and residual standard deviations σ as well as the latent
variables γ. These variables are dependent on each other.
From the posterior probabilities of the indicator variables
Bayes Factors were computed as the posterior odds divided
by the prior odds for including a predictor in the model [14].ays calculated as the number of overlapping genes divided by
with a posterior probability larger than 0.99. The names of the KEGG
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O rnmð Þ where r is the number of iterations of the simula-
tion, n is the total number of genes in all the KEGG path-
ways, and m is the number of KEGG pathways. It is clear
that the number of possible models and the dimensional
problem do not drastically affect the computation time.
This is mainly because computationally demanding matrix
multiplications are avoided. The combinatorial problem is
also reduced, because the Markov chain converges to the
posterior distribution of the model probabilities.
Ultimately, this method would be reasonably fast but still
able to account for overlaps among the gene sets. The identi-
fication of gene sets is based on the average t-statistic for the
genes in the set, and therefore there is no principle relation-
ship between the size of the gene set and the chance of
selecting a gene set for the model. The variable selection
method was implemented in the software package iBay
(www.bayz.biz) [15].
Genome-wide expression data in relation to bovine mastitis
We demonstrated our approach using data from a genome-
wide expression study of mastitis in dairy cattle [16]. The
aim was to identify the global changes in mammary gland
gene expression associated with bovine E. coli-induced mas-
titis during the acute and chronic stage of the infection in0 0.4 1
Value
Color Key
Figure 2 Dendrogram showing the relative overlaps among the KEGG
divided by the smaller of the two sets. Only the KEGG pathways with a
of Benjamini and Yekutieli [12], are shown. The black bars on the left-handearly lactating dairy cows. Sixteen healthy Danish
Holstein-Friesian cows were challenged intra-mamma-
rily with E. coli 4 to 6 weeks after parturition. Udder
tissue biopsies were collected ante-mortem from dairy
cows during the acute (24 h) and the chronic (192 h)
stages of the E. coli infection. Further experimental
details can be found in the original publication [16].
Gene expression was measured using the Bovine Gen-
ome array (Affymetrix, Santa Clara, CA). The array con-
tained 24128 probe sets that represented 11030 Entrez
genes. The Bovine Genome Array annotation available
from the NetAffx™ Analysis Centre (Bovine.na29.annot.csv)
was used as well as bovine.db (version 2.3.5) in Bioconduc-
tor [17]. In total, 3130 Entrez genes were assigned to KEGG
pathways using the package org.Bt.eg.db (version 2.3.5).
The primary gene expression data were analyzed using
R (version 2.10.1) [18]. Normalization of the expression
values for the udder was performed using the Robust
Multi-array Average algorithm implemented in the Affy
package (version 1.24.2) [19]. Differential expression of
individual genes was computed using linear modeling
and empirical Bayes methods, which were implemented
in the R package Limma (version 3.2.2) [20]. The linear
models allowed for changes in the time-points. The
time-points were 24 h and 192 h. The contrast used waspathways calculated as the number of overlapping genes
p-value less than 0.000001, adjusted for multiple testing by the method















Figure 3 Heat-map showing the dendrogram from the overlaps among all KEGG pathways; the points represent posterior Pearson
correlations between the indicator variables, generated by Gibbs sampling, corresponding to all the KEGG pathways. The latent
variables could be either one or zero, indicating that a particular KEGG pathway is included in or excluded from the model, respectively. A positive
posterior correlation would indicate pathways that are selected together in the model; and a negative correlation would indicate pathways that
tend to be included in the model alternately. Ending to only select one of them at the time but not the other one or select the second one but
not the first one.
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computed for each gene targeted by a probe. This was
the per-gene summary statistic used as the response vari-
able z in the linear model described above.
Results and discussion
The complete data are shown in Additional file 3.
Consideration of pathway overlaps
The relative overlaps among the pathways were calculated
by dividing the number of overlapping genes by the size of
the smaller of the two overlapping pathways, to test
whether they affect the outcome of the variable selection
procedure. The heat-map in Figure 1 shows the overlaps
among the pathways and the highly ranked KEGG path-
ways. Many of the high-ranking pathways were among the
less-overlapping pathways. In the clusters of highlyoverlapping pathways, there were only one or a few high-
ranking pathways or even none in some cases. This is
expected because the Bayesian variable selection proced-
ure considers overlaps. If the method did not consider the
overlaps among pathways there would be cases of highly
overlapping pathways being highly ranked by the selection
procedure at the same time if many of the overlapping
genes were differentially expressed. When using the
ANOVA method that does not take overlaps into account,
there were several gene sets that were highly overlapping
among the most highly ranked gene sets (Figure 2).
The KEGG pathways were also connected to their latent
variables containing information about whether the path-
way was included in the Gibbs sampling round. The Pear-
son correlations between the latent variables were
computed. A positive posterior correlation would indicate





































Figure 4 Two histograms show the number of pathways with
different posterior probabilities of being included in the model
(0.05 on the left and 0.40 on the right).
Skarman et al. BMC Bioinformatics 2012, 13:73 Page 6 of 9
http://www.biomedcentral.com/1471-2105/13/73negative correlation would indicate pathways that tend to
be included in the model alternately. These correlations
for each pathway are shown in Figure 3, while the dendro-
gram is based on clustering according to their relative
overlaps in Figure 1. The correlations do not, in general,
follow a particular pattern. The highly correlated pathways
are not clustered together in a pattern similar to that
shown in Figure 1. This shows that the overlapping path-
ways are not selected together.
Influence of prior probability on the latent variables
We assessed the robustness of the selection procedure to
different levels of prior probabilities for the latent variable
by increasing the probability from 0.05 to 0.40, which cor-
responds to including more pathways in each step of the
Gibbs sampling. This resulted in more pathways with a
posterior probability between the extremes of zero and
one (Figure 4), but the most highly ranked pathways did
not change. The 30 most highly ranking pathways were
identical for the two prior probabilities. This shows that
variable selection for this particular data-set is robust to a
change in prior probability. However, we recommend that
the influence of the prior probability be assessed for each
data-set. This sensitivity analysis can also be useful be-
cause there are potential mixing problems of the sampler,
as SSVS is known to suffer from slow mixing if the prior
probability of the latent variable is too small [14].
Comparison to the ANOVA approach
We compared the results from the Bayesian variable selec-
tion procedure to those of an ANOVA approach that ignoresthe overlaps among gene sets. The KEGG pathways highly
ranked by the ANOVA approach are shown in Figure 2.
From this heat-map it appears that the ANOVA approach
ranks highly overlapping pathways together. Another way of
investigating this tendency is that if the overlapping gene sets
tend to be ranked similarly, the differences among the rank-
ing scores would be negatively correlated to the relative
overlaps. If the gene sets that are highly overlapping do not
tend to have a similar score, the correlation would be zero
or close to zero. For the ANOVA method, the p-values were
used as scores and the Spearman correlation was −0.34. For
the variable selection method, the Spearman correlation was
−0.0063. It appears that the ANOVA approach tends to rank
overlapping gene sets similarly while the Bayesian variable
selection approach does not.
One illustrative example is the ‘Focal Adhesion’ path-
way that contains 152 genes. It was considered highly
significant by the ANOVA approach. Using the Bayesian
variable selection procedure, however, it had a very low
posterior probability (0.013) of being included in the
model. Therefore, it is unlikely to play an important role
in the acute phase response in the udder. The discrep-
ancy can be explained because it has a large overlap (50
genes) with the ‘Extracellular Matrix (ECM)-receptor
Interaction’ pathway, which is highly ranked by the vari-
able selection method. In total, ‘ECM-receptor Inter-
action’ contains 63 genes. By the Bayesian method, the
‘Focal Adhesion’ pathway does not contribute greatly
once the ‘ECM-receptor Interaction’ pathway is taken
into account. The overlap between ‘Focal Adhesion’ and
‘Extracellular Matrix (ECM)-receptor Interaction’ is
shown in a Venn diagram in Additional file 4.
Cases of highly overlapping pathways
When the genes are highly overlapping in two pathways
it can be difficult for the Bayesian variable selection pro-
cedure to select one of them. Consider for example
the following two simple pathways: A->B->C and B->
C->D. These pathways overlap by genes B and C, and it
would be hard to distinguish the more influential path-
way if genes B and C were highly expressed. In the vari-
able selection procedure, one of the pathways would be
included in the model interchangeably. This is reflected
in the posterior correlation for the latent variables. If the
two pathways were interchangeably included in the
model the correlation would be negative. We searched
for examples of pathways with a high overlap and a
negative posterior correlation. For both prior probabil-
ities for the latent variable, the posterior correlations
were centered on zero with the majority (95–98%) of the
posterior samples being between −0.1 and 0.1.
When using a prior probability of 0.05 of including a
pathway in the model, there were only two examples of low
posterior correlation below −0.1 and a large overlap: ‘Tight
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correlation was −0.15 and the relative overlap was 0.43.
This was not an example of a pair of pathways that were
hard to discriminate, because ‘Tight Junction’ had a high
posterior probability (0.94) and ‘Leukocyte Transendothelial
Migration’ had a low posterior probability (0.013).
When using a prior probability of including the pathways
in the model of 0.4, the two pathways ‘Huntington’s Disease’
and ‘Parkinson’s Disease’ were noteworthy. These two path-
ways are both involved in neurodegenerative diseases and
have a negative posterior correlation of −0.37. Their relative
overlap was 0.81. Neither pathway had a much higher pos-
terior than prior probability of being included in the model.Table 1 30 top-ranked KEGG pathways using a prior probabil




ABC transporters 24 1
Lysosome 90 1
Proteasome 40 1
Complement and coagulation cascades 53 1
RIG-I-like receptor signaling pathway 44 1
ECM-receptor interaction 63 1
Cell adhesion molecules (CAMs) 95 1
Axon guidance 79 1
SNARE interactions in vesicular transport 31 1
RNA degradation 49 1
Ubiquitin mediated proteolysis 105 1
Neuroactive ligand-receptor interaction 125 1
PPAR signaling pathway 58 1
Ribosome 76 1
MAPK signaling pathway 179 1
Aminoacyl-tRNA biosynthesis 34 1
Endocytosis 139 1
Fc gamma R-mediated phagocytosis 70 1
Insulin signaling pathway 97 1
Cell cycle 96 1
Notch signaling pathway 31 1
Cytokine-cytokine receptor interaction 115 1
Chemokine signaling pathway 138 1
Metabolic pathways 793 1
Tight junction 97 0.938
Purine metabolism 117 0.927
Chronic myeloid leukemia 58 0.919
Pathways in cancer 227 0.847
Basal transcription factors 23 0.826
Circadian rhythm - mammal 5 0.590
“Odds ratio” indicates the odds ratio between the prior and posterior probability of
variance of the t-statistic per gene. The gene sets are ranked primarily according toHowever, both were highly ranked by the ANOVA method.
This provides an example of two pathways that are hard to
discriminate by the Bayesian variable selection method. On
the other hand, it also illustrates a feature of the variable se-
lection procedure that permits a deeper insight into biologic-
ally relevant expression patterns in the data.
The top-ranked pathways
The 30 top-ranked pathways are shown in Table 1. These
top-ranked pathways are primarily characterized by activa-
tion of the immune response. The response is manifested
by 1) lysis of bacteria and cells via lysosome, complement,
and coagulation cascades and Fc gamma R-mediatedity of 0.05
ior probability of
included in the model
































being included in the model. “Variance per gene” means the estimated
the posterior probabilities and secondarily according to the variance per gene.
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indicated by cell adhesion molecules and chemokine sig-
naling pathways; and 3) cell differentiation and prolifera-
tion led by ECM-receptor interactions, cytokine-cytokine
receptor interactions, and the MAPK signaling pathway.
Another important observation regarding the highly
ranked pathways is the presence of several metabolic path-
ways such as aminoacyl-tRNA biosynthesis, purine metab-
olism, and ABC transporters. It is worth noting the
presence of signaling pathways that regulate a variety of
cellular functions, including inflammation and metabol-
ism. For example, the PPAR signaling pathway regulates
ABC lipid transporters and is a molecular link between
the immune system and macronutrient metabolism [21].
As shown in Table 1, a potential limitation is that it was
not possible to discriminate among the 24 most highly
ranked gene sets in terms of significance using the poster-
ior probability of being included in the model or the odds
ratio between the prior and posterior probabilities. To dis-
tinguish them, it may be helpful to study the variance
explained per gene by each of the sets. ‘ABC Transporters’
and ‘Lysosome’ were the two most highly ranked gene sets
using this way of ranking. However, neither of these was
identified in a hypergeometric gene set enrichment study
on gene sets defined by KEGG pathways taking only the
differentially expressed genes [16].
Robustness to a limited number of observations
Our gene set approach uses a moderated t-statistic, the
per-gene summary statistic, as the response variable. The
summary statistics were computed for each of the 3130
genes linked to KEGG pathways, but were based on a
limited number of observations—only eight animals in
each treatment group in this study. We assessed the in-
fluence of a limited number of observations on the ro-
bustness of the high-ranking pathways by randomly
selecting a subset of the animals, computing the moder-
ated t-statistics, and running the variable selection pro-
cedure. We repeated this 120 times, eliminating the data
from two animals at a time, and recorded the rankings of
the pathways in each round. Among the 30 highest-rank-
ing pathways in each round, 26 pathways appeared in all
120 runs. Although these results suggest that our ap-
proach is robust in cases where there is a limited number
of observations, we suggest that this type of analysis
should be performed for each data-set.
Conclusions
Bayesian variable selection can prioritize gene sets while also
considering the overlaps among them. This can be per-
formed for a large number of genes without overwhelmingly
demanding computation. The selection method tends to se-
lect one or a few pathways among the highly overlapping
pathways. It also makes it possible to determine which pairsof overlapping pathways are harder to prioritize. This can be
achieved by studying the latent variables computed in the
variable selection.
Our results show that the ANOVA approach can give
misleading results by not considering the pathway over-
laps. The Bayesian variable selection method gave similar
results to the ANOVA method, but it was able to high-
light one or a few among the highly overlapping genes.
Cases that would prove difficult for the Bayesian vari-
able selection method include when there are very highly
overlapping genes and the overlapping genes are differ-
entially expressed. In such cases, we suggest that the
posterior correlations among highly overlapping path-
ways should be examined to determine whether they are
negative and have a high absolute value.
Additional files
Additional file 1: Matrix where the rows represent the genes with
their Entrez gene identifiers. The columns represent the Kyoto
Encyclopedia of Genes and Genomes pathways. The elements can have
the values zero or one. The value zero means that the gene is not in the
pathway whereas the value one means that the gene is in the pathway.
Additional file 2: Details of the Bayesian analysis.
Additional file 3: Table showing the full list of gene sets, defined
according to KEGG pathways, ranked according to the variable
selection method. “Odds_ratio” means the odds ratio between the
prior and posterior probability for the gene set of being included in
the model. This is used as a Bayes factor to judge the significance. “Inf”
indicates infinity, which is the evaluated Bayes Factor when the posterior
probability is 1. “Explained variance” is the average variance explained by
the t-statistic per gene in the gene set.
Additional file 4: The Venn diagram is showing the overlap of
genes between the pathways ‘Focal Adhesion’ and ‘Extracellular
Matrix (ECM)-receptor Interaction’. ‘Focal adhesion’ was highly ranked
by the ANOVA method but had a low posterior probability (0.013) of
being included in the model when using the Bayesian method. A
plausible reason for this is the high overlap with the pathway
‘Extracellular Matrix (ECM)-receptor Interaction’, which had a posterior
probability 1 of being included in the model. These results indicate that
‘Focal Adhesion’ was ranked high in the ANOVA due to ‘guilt by
association’ with the ‘ECM-receptor interaction’ pathway.
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